A Comprehensive Analysis of Adverse Events in the First 30 Days of Phase 1 Pediatric CAR T-Cell Trials
- Sara K Silbert, Sanna Madan, Elizabeth M Holland, …, Haneen Shalabi, Bonnie Yates, Nirali N Shah
- Blood Adv, 10.1182/bloodadvances.2023009789
Immune Resistance Mechanisms and the Road to Personalized Immunotherapy
- Miles Piper, Harriet Kluger, Eytan Ruppin, …, Harriet Kluger, Eytan Ruppin, Siwen Hu-Lieskovan
- Am Soc Clin Oncol Educ Book, 10.1200/edbk_390290
Melanoma-intrinsic NR2F6 activity regulates antitumor immunity
- Hyungsoo Kim, Yongmei Feng, Rabi Murad, …, Victoria Klepsch, Gottfried Baier, Ze’ev A Ronai
- Sci Adv, 10.1126/sciadv.adf6621
A landscape of response to drug combinations in non-small cell lung cancer
- Nishanth Ulhas Nair, Patricia Greninger, Xiaohu Zhang, …, Craig J Thomas, Eytan Ruppin, Cyril H Benes
- Nat Commun, 10.1038/s41467-023-39528-9
Medication effects on the gut microbiome in allo-HCT
- Welles Robinson, E Michael Gertz, Tim F Greten, …, E Michael Gertz, Tim F Greten, Eytan Ruppin
- Cell, 10.1016/j.cell.2023.04.011
Glucose-6-phosphate dehydrogenase (G6PD) Deficiency and COVID-19
- Ariel Israel, Matitiahu Berkovitch, Eugene Merzon, …, Eytan Ruppin, Shlomo Vinker, Eli Magen
- Clin Infect Dis, 10.1093/cid/ciad348
Ubiquitin ligases Siah1a/2 control alveolar macrophage functions to limit carcinogen-induced lung adenocarcinoma
- Marzia Scortegagna, Yuanning Du, Linda M Bradley, …, Eytan Ruppin, Rabi Murad, Ze’ev A Ronai
- Cancer Res, 10.1158/0008-5472.can-23-0258
Predicting tumor immune microenvironment and checkpoint therapy response of head & neck cancer patients from blood immune single-cell transcriptomics
- Yingying Cao, Tiangen Chang, Fiorella Schischlik, …, Sridhar Hannenhalli, Peng Jiang, Eytan Ruppin
- None, 10.1101/2023.01.17.524455
Decoupling the correlation between cytotoxic and exhausted T lymphocyte transcriptomic signatures enhances melanoma immunotherapy response prediction
- Binbin Wang, Kun Wang, Peng Jiang, …, Kun Wang, Peng Jiang, Eytan Ruppin
- None, 10.1101/2023.01.17.524482
Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma
- Nishanth Ulhas Nair, Qun Jiang, Jun Stephen Wei, …, Javed Khan, Eytan Ruppin, Raffit Hassan
- Cell Rep Med, 10.1016/j.xcrm.2023.100938
Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma
- Ming Sun, Yingying Cao, Reona Okada, …, Mitchell Ho, Carol J Thiele, Rosa Nguyen
- J Immunother Cancer, 10.1136/jitc-2022-005881
Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome
- Gal Dinstag, Eldad D Shulman, Efrat Elis, …, Tuvik Beker, Eytan Ruppin, Ranit Aharonov
- Med, 10.1016/j.medj.2022.11.001
